CA2329527A1 - Endometriosis-associated gene - Google Patents

Endometriosis-associated gene Download PDF

Info

Publication number
CA2329527A1
CA2329527A1 CA002329527A CA2329527A CA2329527A1 CA 2329527 A1 CA2329527 A1 CA 2329527A1 CA 002329527 A CA002329527 A CA 002329527A CA 2329527 A CA2329527 A CA 2329527A CA 2329527 A1 CA2329527 A1 CA 2329527A1
Authority
CA
Canada
Prior art keywords
polypeptide
nucleic acid
seq
preparation
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002329527A
Other languages
English (en)
French (fr)
Inventor
Anna Starzinski-Powitz
Silvia Kotzian
Heike Handrow-Metzmacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STARZINSKI POWITZ ANNA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2329527A1 publication Critical patent/CA2329527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002329527A 1998-05-29 1999-05-28 Endometriosis-associated gene Abandoned CA2329527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19824230A DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen
DE19824230.1 1998-05-29
PCT/EP1999/003716 WO1999063079A1 (de) 1998-05-29 1999-05-28 Endometriose-assoziiertes gen

Publications (1)

Publication Number Publication Date
CA2329527A1 true CA2329527A1 (en) 1999-12-09

Family

ID=7869409

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002329527A Abandoned CA2329527A1 (en) 1998-05-29 1999-05-28 Endometriosis-associated gene

Country Status (9)

Country Link
US (1) US6586569B1 (enExample)
EP (1) EP1080195A1 (enExample)
JP (1) JP2002517193A (enExample)
CN (1) CN1307636A (enExample)
AU (1) AU765515B2 (enExample)
CA (1) CA2329527A1 (enExample)
DE (1) DE19824230A1 (enExample)
NZ (1) NZ508439A (enExample)
WO (1) WO1999063079A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801236B1 (en) * 2000-02-25 2009-11-18 Siemens Healthcare Diagnostics Inc. Endometriosis related markers and uses thereof
DE60140580D1 (de) 2000-02-25 2009-12-31 Siemens Healthcare Diagnostics Endometriose Marker und Verwendung derselben
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
FR2855315B1 (fr) 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
CN112180099B (zh) * 2020-09-15 2022-07-29 江南大学附属医院 子宫内膜异位症血清标志物的应用
CN113512584B (zh) * 2021-06-24 2022-03-25 南京鼓楼医院 Pbk/topk在诊断和治疗薄型内膜疾病中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4846793A (en) * 1992-09-04 1994-03-29 Baylor College Of Medicine Novel triplex forming oligonucleotides and methods for their use
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
AU687508B2 (en) * 1993-12-17 1998-02-26 Ohio State University, The Antisense oligonucleotides to suppress eicosanoid formation
AU6029396A (en) * 1995-06-07 1996-12-30 University Of Rochester Mammalian prostaglandin h synthase-2
DE19548122A1 (de) * 1995-12-21 1997-06-26 Joern Prof Dr Bullerdiek Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben
JP2001501300A (ja) * 1996-09-06 2001-01-30 オステオメーター・ビオテク・エー／エス ヒト子宮内膜の生化学的マーカー

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9840738B2 (en) 2007-06-11 2017-12-12 Juneau Biosciences, Llc Method of testing for endometriosis and treatment therefor
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor

Also Published As

Publication number Publication date
US6586569B1 (en) 2003-07-01
US20030109018A1 (en) 2003-06-12
EP1080195A1 (de) 2001-03-07
CN1307636A (zh) 2001-08-08
AU765515B2 (en) 2003-09-18
WO1999063079A1 (de) 1999-12-09
JP2002517193A (ja) 2002-06-18
AU4502499A (en) 1999-12-20
NZ508439A (en) 2004-02-27
DE19824230A1 (de) 1999-12-02

Similar Documents

Publication Publication Date Title
Ellmeier et al. Mutually exclusive expression of a helix‐loop‐helix gene and N‐myc in human neuroblastomas and in normal development.
US5985598A (en) TCL-1 gene and protein and related methods and compositions
US7807373B2 (en) Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer
US6100031A (en) Methods for diagnosis of colon cancer by detecting Roch083 mRNA
AU765515B2 (en) Endometriosis-associated gene
US20030005471A1 (en) PAR, a novel marker gene for breast and prostate cancers
WO1997006256A2 (en) Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
US20050287530A1 (en) TCL-1b gene and protein and related methods and compositions
Coy et al. Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms
AU778088B2 (en) Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer
Larsen et al. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers
CA2215793C (en) Use of neuronal apoptosis inhibitor protein (naip)
WO1998012327A2 (en) Compositions and methods comprising bard1 and other brca1 binding proteins
AU1192901A (en) Differentially expressed genes associated with her-2/neu overexpression
JP4190291B2 (ja) 癌細胞の増殖を調節するのに有用なポリヌクレオチド
EP0825198A1 (en) Plag gene family and tumorigenesis
US20080187527A1 (en) Novel endometriosis-associated gene
JP2001186889A (ja) 良性前立腺肥大と関連するポリヌクレオチドおよびポリペプチド
JP4297209B2 (ja) Ｋｉａａ０１７２遺伝子の疾病治療及び診断並びに創薬への利用
AU749907B2 (en) Process for the determination of CTp11 and for determining whether a tumor sample has metastatic potential
US6770477B1 (en) Differentially expressed genes associated with HER-2/neu overexpression
ES2303595T3 (es) Moleculas marcadoras asociadas con tumores pulmonares.
US20030027166A1 (en) Coding sequence haplotype of the human BRCA1 gene
JP2008525045A (ja) ヒトプロトオンコ遺伝子およびそこにコードされるタンパク質
JP2008194045A (ja) ヒト腫瘍細胞において増加調節される核酸、それによりコードされるタンパク質、及び腫瘍の診断方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued